The groundbreaking approach of the medication represents a significant development in the handling of type 2 diabetes. Different to existing drugs, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide731039.techionblog.com/42256510/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment